A combination of compounds found in cannabis showed the potential to treat or even prevent coronavirus infections in human lung cells, according to recently published research. The study, “In Vitro Evaluation of the Activity of Terpenes and Cannabidiol against Human Coronavirus E229,” was published by the peer-reviewed journal Life on March 29.
The research studied the antiviral action of a proprietary formula of terpenes, which are natural volatile compounds found in many plants including cannabis. The formulation, known as NT-VRL, is a combination of 30 terpenes including beta-caryophyllene, eucalyptol and citral developed by cannabis technology company Eybna.
Terpenes have shown the potential to treat a wide variety of viral infections in many in vitro studies, and research released by Eybna last year found that NT-VRL combined with cannabidiol (CBD) showed promise as a treatment for the severe inflammatory response seen in many Covid-19 patients known as a cytokine storm.
– Read the entire article at Forbes.
Bud Digest[otw_is sidebar=otw-sidebar-8]